HAIA vs. DMAQ, JMAC, QFTA, RWOD, ATAK, EFHT, MCAE, WWAC, OLIT, and SELX
Should you be buying Healthcare AI Acquisition stock or one of its competitors? The main competitors of Healthcare AI Acquisition include Deep Medicine Acquisition (DMAQ), Maxpro Capital Acquisition (JMAC), Quantum FinTech Acquisition (QFTA), Redwoods Acquisition (RWOD), Aurora Technology Acquisition (ATAK), EF Hutton Acquisition Co. I (EFHT), Mountain Crest Acquisition Corp. III (MCAE), Worldwide Webb Acquisition (WWAC), OmniLit Acquisition (OLIT), and Semilux International (SELX). These companies are all part of the "holding & other investment offices" industry.
Deep Medicine Acquisition (NASDAQ:DMAQ) and Healthcare AI Acquisition (NASDAQ:HAIA) are both small-cap unclassified companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, profitability, valuation, media sentiment, community ranking, risk, institutional ownership and earnings.
18.4% of Deep Medicine Acquisition shares are held by institutional investors. Comparatively, 79.1% of Healthcare AI Acquisition shares are held by institutional investors. 1.7% of Deep Medicine Acquisition shares are held by insiders. Comparatively, 45.0% of Healthcare AI Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Healthcare AI Acquisition had 1 more articles in the media than Deep Medicine Acquisition. MarketBeat recorded 1 mentions for Healthcare AI Acquisition and 0 mentions for Deep Medicine Acquisition. Deep Medicine Acquisition's average media sentiment score of 0.15 beat Healthcare AI Acquisition's score of 0.00 indicating that Healthcare AI Acquisition is being referred to more favorably in the news media.
Deep Medicine Acquisition has a beta of 0.02, suggesting that its stock price is 98% less volatile than the S&P 500. Comparatively, Healthcare AI Acquisition has a beta of -0.01, suggesting that its stock price is 101% less volatile than the S&P 500.
Deep Medicine Acquisition and Healthcare AI Acquisition both received 0 outperform votes by MarketBeat users.
Summary
Healthcare AI Acquisition beats Deep Medicine Acquisition on 4 of the 5 factors compared between the two stocks.
Get Healthcare AI Acquisition News Delivered to You Automatically
Sign up to receive the latest news and ratings for HAIA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding HAIA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Healthcare AI Acquisition Competitors List
Related Companies and Tools
